N,Title,Authors,Journal,Date,Team,Url 1,"Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.","Meyer B, Chiaravalli J, Gellenoncourt S, Brownridge P, Bryne DP, Daly LA, Grauslys A, Walter M, Agou F, Chakrabarti LA, Craik CS, Eyers CE, Eyers PA, Gambin Y, Jones AR, Sierecki E, Verdin E, Vignuzzi M, Emmott E, ","Nature communications",'2021-09-21,"Chemogenomic and Biological Screening Platform (PF-CCB), Archived: Viral Populations and Pathogenesis, Virus and Immunity, UMR3523 – Chemistry for Life Sciences (Chem4Life)",https://research.pasteur.fr/en/publication/characterising-proteolysis-during-sars-cov-2-infection-identifies-viral-cleavage-sites-and-cellular-targets-with-therapeutic-potential/